Factor VIIa for alveolar hemorrhage in microscopic polyangiitis [3]

American Journal of Respiratory and Critical Care Medicine

Volumn 166, Issue 9, 2002, Pages 1291-1292

  Betensley, Alan D ^a   Yankaskas, James R ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A;

ADULT; ANAMNESIS; CASE REPORT; CAUSE OF DEATH; CLINICAL EXAMINATION; DYSPNEA; HUMAN; LETTER; LUNG HEMORRHAGE; MALE; PRIORITY JOURNAL; RESPIRATORY FAILURE; VASCULITIS;

EID: 0036840480     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.166.9.267d     Document Type: Letter

References (9)

1. Lauque D, Cadranel J, Lazor R, Pourrat J, Ronco P, Guillevin L, Cordier J. Microscopic polyangiitis with alveolar hemorrhage: A study of 29 cases and review of the literature. Medicine (Baltimore) 2000;79:222-233.
2. Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 1997;99:542-547.
3. Roberts HR. Recombinant factor VIIa (NovoSeven®) and the safety of treatment. Semin Hematol 2001;38(Suppl 12):48-50.
4. Akarsu M, Demirkan F, Ozsan GH, Onen F, Yuksel F, Ozkan S, Undar B. Increased levels of tissue factor pathway inhibitor may reflect disease activity and play a role in thrombotic tendency in Bechet's disease. Am J Hematol 2001;68:225-230.
5. Sabharwal AK, Bajaj SP, Ameri A, Tricomi SM, Hyers TM, Dahms TE, Taylor FB, Bajaj MS. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis. Am J Respir Crit Care Med 1995:151:758-767.
6. Meijer K, de Graaff WE, Daenen SMGJ, van der Meer J. Successful treatment of massive hemoptysis in acute leukemia with recombinant factor VIIa. Arch Intern Med 2000;160:2216-2227.
7. Vlot AJ, Ton E, Mackaay AJC, Kramer MHH, Gaillard CAJM. Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII. Am J Med 2000;108:421-422.
8. Lindley CM, Sawyer WT, Macik BG, Lusher J, Harrison JF, Baird-Cox K, Birch K, Glazer S, Roberts HR. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa. Clin Pharmacol Ther 1994;55:638-648.
9. Hedner U. Recombinant factor VIIa (NovoSeven®) as a hemostatic agent. Semin Hematol 2001;38(Suppl 12):43-47.